nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Topotecan—Irinotecan—colon cancer	0.0468	1	CbGdCrCtD
Emtricitabine—Floxuridine—TYMS—colon cancer	0.0391	0.885	CrCbGaD
Emtricitabine—Urine output increased—Vincristine—colon cancer	0.00742	0.00816	CcSEcCtD
Emtricitabine—Rash maculo-papular—Fluorouracil—colon cancer	0.00695	0.00765	CcSEcCtD
Emtricitabine—Otitis media—Capecitabine—colon cancer	0.00687	0.00756	CcSEcCtD
Emtricitabine—Multiple fractures—Methotrexate—colon cancer	0.00685	0.00754	CcSEcCtD
Emtricitabine—Fracture—Methotrexate—colon cancer	0.00685	0.00754	CcSEcCtD
Emtricitabine—Polyuria—Vincristine—colon cancer	0.00678	0.00746	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Methotrexate—colon cancer	0.00669	0.00736	CcSEcCtD
Emtricitabine—Renal failure acute—Irinotecan—colon cancer	0.00628	0.00691	CcSEcCtD
Emtricitabine—Renal impairment—Irinotecan—colon cancer	0.00609	0.0067	CcSEcCtD
Emtricitabine—Proteinuria—Capecitabine—colon cancer	0.00609	0.00669	CcSEcCtD
Emtricitabine—Protein urine present—Capecitabine—colon cancer	0.006	0.0066	CcSEcCtD
Emtricitabine—Skin discolouration—Capecitabine—colon cancer	0.00592	0.00651	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Capecitabine—colon cancer	0.00588	0.00647	CcSEcCtD
Emtricitabine—Dermatitis bullous—Fluorouracil—colon cancer	0.00581	0.00639	CcSEcCtD
Emtricitabine—Bone pain—Capecitabine—colon cancer	0.00558	0.00614	CcSEcCtD
Emtricitabine—Inflammation—Capecitabine—colon cancer	0.00551	0.00606	CcSEcCtD
Emtricitabine—Blood creatinine increased—Irinotecan—colon cancer	0.00543	0.00598	CcSEcCtD
Emtricitabine—Hypokalaemia—Irinotecan—colon cancer	0.00528	0.00581	CcSEcCtD
Emtricitabine—Muscular weakness—Vincristine—colon cancer	0.00525	0.00578	CcSEcCtD
Emtricitabine—Lamivudine—ABCB1—colon cancer	0.0051	0.115	CrCbGaD
Emtricitabine—Neuropathy—Capecitabine—colon cancer	0.00502	0.00552	CcSEcCtD
Emtricitabine—Nasopharyngitis—Fluorouracil—colon cancer	0.00497	0.00546	CcSEcCtD
Emtricitabine—Pancreatitis—Irinotecan—colon cancer	0.00491	0.00541	CcSEcCtD
Emtricitabine—Muscular weakness—Fluorouracil—colon cancer	0.0049	0.00539	CcSEcCtD
Emtricitabine—Urine output increased—Capecitabine—colon cancer	0.00483	0.00532	CcSEcCtD
Emtricitabine—Neutropenia—Vincristine—colon cancer	0.00481	0.00529	CcSEcCtD
Emtricitabine—Neutropenia—Irinotecan—colon cancer	0.00469	0.00516	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Irinotecan—colon cancer	0.00466	0.00513	CcSEcCtD
Emtricitabine—Weight decreased—Vincristine—colon cancer	0.00466	0.00512	CcSEcCtD
Emtricitabine—Pneumonia—Vincristine—colon cancer	0.00462	0.00508	CcSEcCtD
Emtricitabine—Depression—Vincristine—colon cancer	0.00458	0.00503	CcSEcCtD
Emtricitabine—Weight decreased—Irinotecan—colon cancer	0.00453	0.00499	CcSEcCtD
Emtricitabine—Proteinuria—Methotrexate—colon cancer	0.00453	0.00498	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Vincristine—colon cancer	0.0045	0.00495	CcSEcCtD
Emtricitabine—Pneumonia—Irinotecan—colon cancer	0.0045	0.00495	CcSEcCtD
Emtricitabine—Protein urine present—Methotrexate—colon cancer	0.00447	0.00492	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00446	0.00491	CcSEcCtD
Emtricitabine—Polyuria—Capecitabine—colon cancer	0.00442	0.00486	CcSEcCtD
Emtricitabine—Skin discolouration—Methotrexate—colon cancer	0.00441	0.00485	CcSEcCtD
Emtricitabine—Renal failure—Irinotecan—colon cancer	0.00439	0.00483	CcSEcCtD
Emtricitabine—Gastroenteritis—Capecitabine—colon cancer	0.00438	0.00482	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Methotrexate—colon cancer	0.00438	0.00482	CcSEcCtD
Emtricitabine—Pneumonia—Fluorouracil—colon cancer	0.00431	0.00474	CcSEcCtD
Emtricitabine—Infestation NOS—Fluorouracil—colon cancer	0.00428	0.00471	CcSEcCtD
Emtricitabine—Infestation—Fluorouracil—colon cancer	0.00428	0.00471	CcSEcCtD
Emtricitabine—Renal failure acute—Capecitabine—colon cancer	0.0042	0.00463	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Fluorouracil—colon cancer	0.0042	0.00462	CcSEcCtD
Emtricitabine—Urinary tract infection—Fluorouracil—colon cancer	0.00416	0.00458	CcSEcCtD
Emtricitabine—Inflammation—Methotrexate—colon cancer	0.0041	0.00451	CcSEcCtD
Emtricitabine—Renal impairment—Capecitabine—colon cancer	0.00408	0.00449	CcSEcCtD
Emtricitabine—Urinary tract disorder—Vincristine—colon cancer	0.00407	0.00448	CcSEcCtD
Emtricitabine—Dermatitis bullous—Capecitabine—colon cancer	0.00406	0.00447	CcSEcCtD
Emtricitabine—Connective tissue disorder—Vincristine—colon cancer	0.00405	0.00445	CcSEcCtD
Emtricitabine—Urethral disorder—Vincristine—colon cancer	0.00404	0.00444	CcSEcCtD
Emtricitabine—Rhinitis—Irinotecan—colon cancer	0.00402	0.00442	CcSEcCtD
Emtricitabine—Sinusitis—Fluorouracil—colon cancer	0.00402	0.00442	CcSEcCtD
Emtricitabine—Connective tissue disorder—Irinotecan—colon cancer	0.00394	0.00434	CcSEcCtD
Emtricitabine—Rhinitis—Fluorouracil—colon cancer	0.00385	0.00424	CcSEcCtD
Emtricitabine—Pharyngitis—Fluorouracil—colon cancer	0.00381	0.0042	CcSEcCtD
Emtricitabine—Mediastinal disorder—Vincristine—colon cancer	0.00371	0.00408	CcSEcCtD
Emtricitabine—Blood creatinine increased—Capecitabine—colon cancer	0.00364	0.004	CcSEcCtD
Emtricitabine—Immune system disorder—Irinotecan—colon cancer	0.00362	0.00399	CcSEcCtD
Emtricitabine—Mediastinal disorder—Irinotecan—colon cancer	0.00362	0.00398	CcSEcCtD
Emtricitabine—Mental disorder—Vincristine—colon cancer	0.00361	0.00397	CcSEcCtD
Emtricitabine—Urine output increased—Methotrexate—colon cancer	0.0036	0.00396	CcSEcCtD
Emtricitabine—Hypokalaemia—Capecitabine—colon cancer	0.00353	0.00389	CcSEcCtD
Emtricitabine—Breast disorder—Capecitabine—colon cancer	0.00351	0.00386	CcSEcCtD
Emtricitabine—Nasopharyngitis—Capecitabine—colon cancer	0.00347	0.00382	CcSEcCtD
Emtricitabine—Back pain—Vincristine—colon cancer	0.00347	0.00382	CcSEcCtD
Emtricitabine—Muscular weakness—Capecitabine—colon cancer	0.00342	0.00377	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00342	0.00377	CcSEcCtD
Emtricitabine—Back pain—Irinotecan—colon cancer	0.00338	0.00372	CcSEcCtD
Emtricitabine—Anaemia—Vincristine—colon cancer	0.00331	0.00365	CcSEcCtD
Emtricitabine—Polyuria—Methotrexate—colon cancer	0.00329	0.00362	CcSEcCtD
Emtricitabine—Anaemia—Irinotecan—colon cancer	0.00323	0.00355	CcSEcCtD
Emtricitabine—Neutropenia—Capecitabine—colon cancer	0.00314	0.00345	CcSEcCtD
Emtricitabine—Renal failure acute—Methotrexate—colon cancer	0.00313	0.00344	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Capecitabine—colon cancer	0.00312	0.00343	CcSEcCtD
Emtricitabine—Anaemia—Fluorouracil—colon cancer	0.00309	0.0034	CcSEcCtD
Emtricitabine—Myalgia—Vincristine—colon cancer	0.00305	0.00336	CcSEcCtD
Emtricitabine—Cough—Irinotecan—colon cancer	0.00305	0.00335	CcSEcCtD
Emtricitabine—Weight decreased—Capecitabine—colon cancer	0.00304	0.00334	CcSEcCtD
Emtricitabine—Hyperglycaemia—Capecitabine—colon cancer	0.00303	0.00333	CcSEcCtD
Emtricitabine—Pneumonia—Capecitabine—colon cancer	0.00301	0.00331	CcSEcCtD
Emtricitabine—Infestation NOS—Capecitabine—colon cancer	0.00299	0.00329	CcSEcCtD
Emtricitabine—Infestation—Capecitabine—colon cancer	0.00299	0.00329	CcSEcCtD
Emtricitabine—Depression—Capecitabine—colon cancer	0.00298	0.00328	CcSEcCtD
Emtricitabine—Renal failure—Capecitabine—colon cancer	0.00294	0.00323	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Capecitabine—colon cancer	0.00293	0.00323	CcSEcCtD
Emtricitabine—Infection—Vincristine—colon cancer	0.00291	0.0032	CcSEcCtD
Emtricitabine—Urinary tract infection—Capecitabine—colon cancer	0.00291	0.0032	CcSEcCtD
Emtricitabine—Nervous system disorder—Vincristine—colon cancer	0.00287	0.00316	CcSEcCtD
Emtricitabine—Thrombocytopenia—Vincristine—colon cancer	0.00287	0.00315	CcSEcCtD
Emtricitabine—Haematuria—Capecitabine—colon cancer	0.00285	0.00314	CcSEcCtD
Emtricitabine—Myalgia—Fluorouracil—colon cancer	0.00285	0.00313	CcSEcCtD
Emtricitabine—Infection—Irinotecan—colon cancer	0.00283	0.00312	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Capecitabine—colon cancer	0.00283	0.00311	CcSEcCtD
Emtricitabine—Nervous system disorder—Irinotecan—colon cancer	0.0028	0.00308	CcSEcCtD
Emtricitabine—Thrombocytopenia—Irinotecan—colon cancer	0.00279	0.00307	CcSEcCtD
Emtricitabine—Infection—Fluorouracil—colon cancer	0.00271	0.00298	CcSEcCtD
Emtricitabine—Rhinitis—Capecitabine—colon cancer	0.00269	0.00296	CcSEcCtD
Emtricitabine—Hepatitis—Capecitabine—colon cancer	0.00269	0.00295	CcSEcCtD
Emtricitabine—Nervous system disorder—Fluorouracil—colon cancer	0.00268	0.00295	CcSEcCtD
Emtricitabine—Thrombocytopenia—Fluorouracil—colon cancer	0.00267	0.00294	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00267	0.00293	CcSEcCtD
Emtricitabine—Pharyngitis—Capecitabine—colon cancer	0.00267	0.00293	CcSEcCtD
Emtricitabine—Urinary tract disorder—Capecitabine—colon cancer	0.00265	0.00292	CcSEcCtD
Emtricitabine—Insomnia—Vincristine—colon cancer	0.00265	0.00291	CcSEcCtD
Emtricitabine—Connective tissue disorder—Capecitabine—colon cancer	0.00264	0.0029	CcSEcCtD
Emtricitabine—Urethral disorder—Capecitabine—colon cancer	0.00263	0.0029	CcSEcCtD
Emtricitabine—Paraesthesia—Vincristine—colon cancer	0.00263	0.00289	CcSEcCtD
Emtricitabine—Breast disorder—Methotrexate—colon cancer	0.00261	0.00287	CcSEcCtD
Emtricitabine—Insomnia—Irinotecan—colon cancer	0.00258	0.00284	CcSEcCtD
Emtricitabine—Paraesthesia—Irinotecan—colon cancer	0.00256	0.00282	CcSEcCtD
Emtricitabine—Dyspnoea—Irinotecan—colon cancer	0.00254	0.0028	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Vincristine—colon cancer	0.00253	0.00278	CcSEcCtD
Emtricitabine—Fatigue—Vincristine—colon cancer	0.00252	0.00278	CcSEcCtD
Emtricitabine—Dyspepsia—Irinotecan—colon cancer	0.00251	0.00276	CcSEcCtD
Emtricitabine—Pain—Vincristine—colon cancer	0.0025	0.00275	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00249	0.00274	CcSEcCtD
Emtricitabine—Insomnia—Fluorouracil—colon cancer	0.00247	0.00272	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00246	0.00271	CcSEcCtD
Emtricitabine—Fatigue—Irinotecan—colon cancer	0.00246	0.0027	CcSEcCtD
Emtricitabine—Paraesthesia—Fluorouracil—colon cancer	0.00245	0.0027	CcSEcCtD
Emtricitabine—Pancreatitis—Methotrexate—colon cancer	0.00245	0.00269	CcSEcCtD
Emtricitabine—Pain—Irinotecan—colon cancer	0.00244	0.00268	CcSEcCtD
Emtricitabine—Dyspnoea—Fluorouracil—colon cancer	0.00243	0.00268	CcSEcCtD
Emtricitabine—Immune system disorder—Capecitabine—colon cancer	0.00243	0.00267	CcSEcCtD
Emtricitabine—Mediastinal disorder—Capecitabine—colon cancer	0.00242	0.00266	CcSEcCtD
Emtricitabine—Dyspepsia—Fluorouracil—colon cancer	0.0024	0.00264	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Vincristine—colon cancer	0.00239	0.00263	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00236	0.00259	CcSEcCtD
Emtricitabine—Mental disorder—Capecitabine—colon cancer	0.00235	0.00259	CcSEcCtD
Emtricitabine—Malnutrition—Capecitabine—colon cancer	0.00234	0.00257	CcSEcCtD
Emtricitabine—Neutropenia—Methotrexate—colon cancer	0.00234	0.00257	CcSEcCtD
Emtricitabine—Pain—Fluorouracil—colon cancer	0.00233	0.00257	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Irinotecan—colon cancer	0.00233	0.00256	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Methotrexate—colon cancer	0.00232	0.00255	CcSEcCtD
Emtricitabine—Abdominal pain—Vincristine—colon cancer	0.00231	0.00255	CcSEcCtD
Emtricitabine—Body temperature increased—Vincristine—colon cancer	0.00231	0.00255	CcSEcCtD
Emtricitabine—Back pain—Capecitabine—colon cancer	0.00226	0.00249	CcSEcCtD
Emtricitabine—Abdominal pain—Irinotecan—colon cancer	0.00225	0.00248	CcSEcCtD
Emtricitabine—Body temperature increased—Irinotecan—colon cancer	0.00225	0.00248	CcSEcCtD
Emtricitabine—Pneumonia—Methotrexate—colon cancer	0.00224	0.00246	CcSEcCtD
Emtricitabine—Infestation NOS—Methotrexate—colon cancer	0.00223	0.00245	CcSEcCtD
Emtricitabine—Infestation—Methotrexate—colon cancer	0.00223	0.00245	CcSEcCtD
Emtricitabine—Depression—Methotrexate—colon cancer	0.00222	0.00244	CcSEcCtD
Emtricitabine—Renal failure—Methotrexate—colon cancer	0.00219	0.00241	CcSEcCtD
Emtricitabine—Urticaria—Fluorouracil—colon cancer	0.00217	0.00239	CcSEcCtD
Emtricitabine—Anaemia—Capecitabine—colon cancer	0.00216	0.00238	CcSEcCtD
Emtricitabine—Body temperature increased—Fluorouracil—colon cancer	0.00216	0.00237	CcSEcCtD
Emtricitabine—Hypersensitivity—Vincristine—colon cancer	0.00216	0.00237	CcSEcCtD
Emtricitabine—Haematuria—Methotrexate—colon cancer	0.00212	0.00234	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Methotrexate—colon cancer	0.00211	0.00232	CcSEcCtD
Emtricitabine—Hypersensitivity—Irinotecan—colon cancer	0.0021	0.00231	CcSEcCtD
Emtricitabine—Asthenia—Vincristine—colon cancer	0.0021	0.00231	CcSEcCtD
Emtricitabine—Asthenia—Irinotecan—colon cancer	0.00205	0.00225	CcSEcCtD
Emtricitabine—Cough—Capecitabine—colon cancer	0.00204	0.00224	CcSEcCtD
Emtricitabine—Hypersensitivity—Fluorouracil—colon cancer	0.00201	0.00221	CcSEcCtD
Emtricitabine—Diarrhoea—Vincristine—colon cancer	0.002	0.0022	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—colon cancer	0.002	0.0022	CcSEcCtD
Emtricitabine—Arthralgia—Capecitabine—colon cancer	0.00199	0.00219	CcSEcCtD
Emtricitabine—Myalgia—Capecitabine—colon cancer	0.00199	0.00219	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—colon cancer	0.00198	0.00218	CcSEcCtD
Emtricitabine—Anxiety—Capecitabine—colon cancer	0.00198	0.00218	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00198	0.00217	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—colon cancer	0.00197	0.00217	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—colon cancer	0.00196	0.00216	CcSEcCtD
Emtricitabine—Diarrhoea—Irinotecan—colon cancer	0.00195	0.00215	CcSEcCtD
Emtricitabine—Dizziness—Vincristine—colon cancer	0.00194	0.00213	CcSEcCtD
Emtricitabine—Pruritus—Fluorouracil—colon cancer	0.00193	0.00212	CcSEcCtD
Emtricitabine—Infection—Capecitabine—colon cancer	0.0019	0.00209	CcSEcCtD
Emtricitabine—Dizziness—Irinotecan—colon cancer	0.00188	0.00207	CcSEcCtD
Emtricitabine—Nervous system disorder—Capecitabine—colon cancer	0.00187	0.00206	CcSEcCtD
Emtricitabine—Diarrhoea—Fluorouracil—colon cancer	0.00187	0.00205	CcSEcCtD
Emtricitabine—Thrombocytopenia—Capecitabine—colon cancer	0.00187	0.00205	CcSEcCtD
Emtricitabine—Vomiting—Vincristine—colon cancer	0.00186	0.00205	CcSEcCtD
Emtricitabine—Skin disorder—Capecitabine—colon cancer	0.00185	0.00204	CcSEcCtD
Emtricitabine—Rash—Vincristine—colon cancer	0.00185	0.00203	CcSEcCtD
Emtricitabine—Dermatitis—Vincristine—colon cancer	0.00184	0.00203	CcSEcCtD
Emtricitabine—Headache—Vincristine—colon cancer	0.00183	0.00202	CcSEcCtD
Emtricitabine—Vomiting—Irinotecan—colon cancer	0.00181	0.00199	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—colon cancer	0.00181	0.00199	CcSEcCtD
Emtricitabine—Dizziness—Fluorouracil—colon cancer	0.00181	0.00199	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—colon cancer	0.0018	0.00198	CcSEcCtD
Emtricitabine—Rash—Irinotecan—colon cancer	0.0018	0.00198	CcSEcCtD
Emtricitabine—Dermatitis—Irinotecan—colon cancer	0.0018	0.00198	CcSEcCtD
Emtricitabine—Headache—Irinotecan—colon cancer	0.00179	0.00196	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—colon cancer	0.00175	0.00193	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—colon cancer	0.00174	0.00191	CcSEcCtD
Emtricitabine—Nausea—Vincristine—colon cancer	0.00174	0.00191	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00174	0.00191	CcSEcCtD
Emtricitabine—Vomiting—Fluorouracil—colon cancer	0.00174	0.00191	CcSEcCtD
Emtricitabine—Insomnia—Capecitabine—colon cancer	0.00173	0.0019	CcSEcCtD
Emtricitabine—Rash—Fluorouracil—colon cancer	0.00172	0.00189	CcSEcCtD
Emtricitabine—Dermatitis—Fluorouracil—colon cancer	0.00172	0.00189	CcSEcCtD
Emtricitabine—Paraesthesia—Capecitabine—colon cancer	0.00171	0.00188	CcSEcCtD
Emtricitabine—Headache—Fluorouracil—colon cancer	0.00171	0.00188	CcSEcCtD
Emtricitabine—Dyspnoea—Capecitabine—colon cancer	0.0017	0.00187	CcSEcCtD
Emtricitabine—Nausea—Irinotecan—colon cancer	0.00169	0.00186	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—colon cancer	0.00168	0.00185	CcSEcCtD
Emtricitabine—Dyspepsia—Capecitabine—colon cancer	0.00168	0.00185	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00165	0.00181	CcSEcCtD
Emtricitabine—Fatigue—Capecitabine—colon cancer	0.00164	0.00181	CcSEcCtD
Emtricitabine—Pain—Capecitabine—colon cancer	0.00163	0.00179	CcSEcCtD
Emtricitabine—Nausea—Fluorouracil—colon cancer	0.00162	0.00178	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—colon cancer	0.00161	0.00177	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Capecitabine—colon cancer	0.00156	0.00172	CcSEcCtD
Emtricitabine—Cough—Methotrexate—colon cancer	0.00152	0.00167	CcSEcCtD
Emtricitabine—Urticaria—Capecitabine—colon cancer	0.00152	0.00167	CcSEcCtD
Emtricitabine—Abdominal pain—Capecitabine—colon cancer	0.00151	0.00166	CcSEcCtD
Emtricitabine—Body temperature increased—Capecitabine—colon cancer	0.00151	0.00166	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—colon cancer	0.00148	0.00163	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—colon cancer	0.00148	0.00163	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00147	0.00162	CcSEcCtD
Emtricitabine—Infection—Methotrexate—colon cancer	0.00141	0.00155	CcSEcCtD
Emtricitabine—Hypersensitivity—Capecitabine—colon cancer	0.00141	0.00155	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—colon cancer	0.00139	0.00153	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—colon cancer	0.00139	0.00153	CcSEcCtD
Emtricitabine—Skin disorder—Methotrexate—colon cancer	0.00138	0.00152	CcSEcCtD
Emtricitabine—Asthenia—Capecitabine—colon cancer	0.00137	0.00151	CcSEcCtD
Emtricitabine—Pruritus—Capecitabine—colon cancer	0.00135	0.00148	CcSEcCtD
Emtricitabine—Diarrhoea—Capecitabine—colon cancer	0.00131	0.00144	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00129	0.00142	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—colon cancer	0.00128	0.00141	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—colon cancer	0.00128	0.0014	CcSEcCtD
Emtricitabine—Dyspnoea—Methotrexate—colon cancer	0.00127	0.00139	CcSEcCtD
Emtricitabine—Dizziness—Capecitabine—colon cancer	0.00126	0.00139	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—colon cancer	0.00125	0.00138	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00123	0.00135	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—colon cancer	0.00122	0.00135	CcSEcCtD
Emtricitabine—Pain—Methotrexate—colon cancer	0.00121	0.00134	CcSEcCtD
Emtricitabine—Vomiting—Capecitabine—colon cancer	0.00121	0.00133	CcSEcCtD
Emtricitabine—Rash—Capecitabine—colon cancer	0.0012	0.00132	CcSEcCtD
Emtricitabine—Dermatitis—Capecitabine—colon cancer	0.0012	0.00132	CcSEcCtD
Emtricitabine—Headache—Capecitabine—colon cancer	0.0012	0.00131	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methotrexate—colon cancer	0.00116	0.00128	CcSEcCtD
Emtricitabine—Nausea—Capecitabine—colon cancer	0.00113	0.00125	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—colon cancer	0.00113	0.00124	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—colon cancer	0.00112	0.00124	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—colon cancer	0.00112	0.00124	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—colon cancer	0.00105	0.00115	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—colon cancer	0.00102	0.00112	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—colon cancer	0.001	0.00111	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—colon cancer	0.000972	0.00107	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—colon cancer	0.000939	0.00103	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—colon cancer	0.000903	0.000993	CcSEcCtD
Emtricitabine—Rash—Methotrexate—colon cancer	0.000895	0.000985	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—colon cancer	0.000895	0.000984	CcSEcCtD
Emtricitabine—Headache—Methotrexate—colon cancer	0.00089	0.000979	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—colon cancer	0.000844	0.000928	CcSEcCtD
